Deepening International Influence: NHRI and AACR Sign MOU for Cancer Research
The National Health Research Institutes (NHRI) and the American Association for Cancer Research (AACR) have signed a Memorandum of Understanding (MOU) for a five-year strategic partnership to promote cancer research and professional development. This collaboration aims to deepen the international influence of Taiwan's cancer research.
📋 Article Processing Timeline
- 📰 Published: April 21, 2026 at 13:33
- 🔍 Collected: April 21, 2026 at 14:01 (28 min after Published)
- 🤖 AI Analyzed: April 21, 2026 at 19:20 (5h 18m after Collected)
Central News Agency
(Central News Agency reporter Tseng Yi-ning, Taipei, 21st) To deepen the international influence of Taiwan's cancer research, the National Health Research Institutes (NHRI) and the American Association for Cancer Research (AACR) have signed a Memorandum of Understanding (MOU), establishing a five-year strategic partnership through six major cooperation guidelines to jointly promote cancer research and professional development.
The American Association for Cancer Research (AACR), founded in 1907, is the world's first and largest professional organization for cancer research, bringing together scientists and clinical experts globally. It focuses on basic, translational, and clinical research, dedicated to preventing and treating cancer; it also actively collaborates with relevant institutions to make significant contributions to improving the quality of life for cancer patients.
The National Health Research Institutes announced today via a press release that during the 2026 annual meeting held in San Diego, the MOU was officially signed on the morning of the 20th local time by NHRI President Dr. Shih-Hui Kang and AACR CEO Margaret Foti. This continues the key topics focused on by "AACR on Campus," including immunotherapy, cancer genomics analysis, and the application of artificial intelligence in medical research.
Both parties are committed to assisting in enhancing the international competitiveness of young scholars; jointly organizing international scientific conferences, specialized seminars, and training courses; promoting the exchange and sharing of scientific and clinical data information; advancing transnational collaborative research projects and jointly publishing academic papers; providing professional development and training programs for young scholars and clinicians; jointly advocating for oncology-related policies; and facilitating exchanges and mutual dispatches of visiting scholars, researchers, and trainees, covering six major areas of cooperation.
In her speech, Foti mentioned that during a visit to Taiwan many years ago, she visited Academia Sinica and was deeply impressed by the vitality of Taiwan's academic community. She also noted that Taiwanese researchers are increasingly influential on the international stage, with over 600 Taiwanese members in the AACR, accounting for nearly 10% of the Asia-Pacific region, making them an important pillar in promoting global translational cancer research.
Dr. Shih-Hui Kang stated that the first research unit established by NHRI was the Cancer Research Institute. Since its establishment, it has built cooperative relationships with major domestic clinical medical centers to jointly strengthen Taiwan's clinical cancer research and its integration with international standards. Coinciding with NHRI's 30th anniversary, the signing of this MOU not only demonstrates Taiwan's important role in global cancer research but also fulfills its commitment to translating cutting-edge scientific discoveries into clinical applications. (Editor: Wu Su-jou) 1150421
Choose to stand with facts; every sponsorship is a force for safeguarding press freedom.
Download the Central News Agency's "First-hand News" APP to stay updated with the latest news.
Text, images, and videos on this website may not be reproduced, publicly broadcast, or publicly transmitted and used without authorization.
(Central News Agency reporter Tseng Yi-ning, Taipei, 21st) To deepen the international influence of Taiwan's cancer research, the National Health Research Institutes (NHRI) and the American Association for Cancer Research (AACR) have signed a Memorandum of Understanding (MOU), establishing a five-year strategic partnership through six major cooperation guidelines to jointly promote cancer research and professional development.
The American Association for Cancer Research (AACR), founded in 1907, is the world's first and largest professional organization for cancer research, bringing together scientists and clinical experts globally. It focuses on basic, translational, and clinical research, dedicated to preventing and treating cancer; it also actively collaborates with relevant institutions to make significant contributions to improving the quality of life for cancer patients.
The National Health Research Institutes announced today via a press release that during the 2026 annual meeting held in San Diego, the MOU was officially signed on the morning of the 20th local time by NHRI President Dr. Shih-Hui Kang and AACR CEO Margaret Foti. This continues the key topics focused on by "AACR on Campus," including immunotherapy, cancer genomics analysis, and the application of artificial intelligence in medical research.
Both parties are committed to assisting in enhancing the international competitiveness of young scholars; jointly organizing international scientific conferences, specialized seminars, and training courses; promoting the exchange and sharing of scientific and clinical data information; advancing transnational collaborative research projects and jointly publishing academic papers; providing professional development and training programs for young scholars and clinicians; jointly advocating for oncology-related policies; and facilitating exchanges and mutual dispatches of visiting scholars, researchers, and trainees, covering six major areas of cooperation.
In her speech, Foti mentioned that during a visit to Taiwan many years ago, she visited Academia Sinica and was deeply impressed by the vitality of Taiwan's academic community. She also noted that Taiwanese researchers are increasingly influential on the international stage, with over 600 Taiwanese members in the AACR, accounting for nearly 10% of the Asia-Pacific region, making them an important pillar in promoting global translational cancer research.
Dr. Shih-Hui Kang stated that the first research unit established by NHRI was the Cancer Research Institute. Since its establishment, it has built cooperative relationships with major domestic clinical medical centers to jointly strengthen Taiwan's clinical cancer research and its integration with international standards. Coinciding with NHRI's 30th anniversary, the signing of this MOU not only demonstrates Taiwan's important role in global cancer research but also fulfills its commitment to translating cutting-edge scientific discoveries into clinical applications. (Editor: Wu Su-jou) 1150421
Choose to stand with facts; every sponsorship is a force for safeguarding press freedom.
Download the Central News Agency's "First-hand News" APP to stay updated with the latest news.
Text, images, and videos on this website may not be reproduced, publicly broadcast, or publicly transmitted and used without authorization.